http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1085731-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db16ded9b0a5aa6c3915e30a831608a6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate | 1977-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1980-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a8deb0248de0125d1a0ab78ba44250 |
| publicationDate | 1980-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1085731-A |
| titleOfInvention | Treatment of rheumatoid arthritis and related diseases |
| abstract | Abstract It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent or these diseases. It has been discovered that clotrimazole [bis-phenyl,(2-chlorphenyl)-1-imidazolyl-methane] and related com-pounds, antimycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases. |
| priorityDate | 1977-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.